Human/Mouse/Rat BDNF Recombinant Protein, PeproTech

The University of Virginia awarded contract A207_PO-0452576 to Life Technologies Corporation on June 25, 2026, for the procurement of specialized recombinant protein products. The contract encompasses the delivery of Human/Mouse/Rat Brain-Derived Neurotrophic Factor (BDNF) Recombinant Protein manufactured by PeproTech. The total contract value is $203.84, reflecting a single unit purchase. The deliverable is designated for receipt by Dora Bigler Wang at the contracting institution.

This procurement represents a straightforward purchase of research-grade biological materials by the University of Virginia, a Virginia-based state institution. The limited contract scope and unit-based pricing structure indicate this is a supplies purchase rather than a comprehensive service engagement. No specific period of performance is documented in the available contract information, though the June 2026 award date establishes the transaction timeline. Life Technologies Corporation serves as the prime contractor responsible for fulfilling delivery obligations to the specified recipient within the University of Virginia's research operations.